Ibuprofen Tablet
NDC 80425-0537
Product Information
Ibuprofen is a ANDA-approved product labeled by Advanced Rx Of Tennessee, Llc. This medication is typically used as a anti-inflammatory agents. It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 80425-0537 and 5 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
IBU;800 Code Structure Chart
Product Details
What is NDC 80425-0537?
What are the uses of this product?
What are Active Ingredients of this product?
- IBUPROFEN 800 mg/1 - A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- IBUPROFEN (UNII: WK2XYI10QM)
- IBUPROFEN (UNII: WK2XYI10QM) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- STARCH, CORN (UNII: O8232NY3SJ)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- TALC (UNII: 7SEV7J4R1U)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- OPADRY II 32K580000 WHITE (UNII: OQ25C9K54Z)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 197807 - ibuprofen 800 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.